Eurolab is the largest generic oncology company in South Africa and one of the most innovative in cancer management, including treatment therapies and technologies. Eurolab’s whole-of-cancer approach has seen it become a market leader, offering oncologists and their patients an affordable whole-of-cancer solution from diagnosis through to treatment. Founded in 2011, Eurolab began as a company supplying generic oncology medications but quickly grew to become one of South Africa’s most innovative oncology companies offering a range of products and services through four main channels: • Eurolab products (generic oncology medications) • Eurolab Aseptic Unit (ASU) (sterile mixing of cancer IV medicines and cGMP sterile manufacturing) • Gamma Knife SA (radiosurgery technology) and • Oncolab Cellular (gene sequencing machine/ diagnostic tool). Headquartered in Johannesburg, South Africa, Eurolab products and services are currently available across the country. The company is now beginning its expansion into territories on the African continent. Eurolab leadership team Founder: Gabe Simaan Co-founder and CEO: Lynne Du Toit